SCOPUS 정보 검색 플랫폼

Journal of Nervous and Mental Disease

Volumn 191, Issue 4, 2003, Pages 211-218

Placebo response and antidepressant clinical trial outcome

(4) Khan, Arif a,b Detke, Michael c,d,e,f Khan, Shirin R F a Mallinckrodt, Craig c

a Northwest Clinical Research Center (United States)

b DUKE UNIVERSITY MEDICAL CENTER (United States)

c ELI LILLY AND COMPANY (United States)

d INDIANA UNIVERSITY SCHOOL OF MEDICINE (United States)

e MCLEAN HOSPITAL (United States)

f HARVARD MEDICAL SCHOOL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; PLACEBO; SERTRALINE; VENLAFAXINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG APPROVAL; DRUGS, INVESTIGATIONAL; HUMANS; PLACEBO EFFECT; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0242499886 PISSN: 00223018 EISSN: None Source Type: Journal
DOI: 10.1097/00005053-200304000-00001 Document Type: Article

Times cited : (161)

References (9)

1
- 0242469511
- Newcastle rating scale
- Carney MPW, Roth M, Garside RF (1965) Newcastle rating scale. Br J Psychiatry 111:695-674.
- (1965) Br J Psychiatry , vol.111 , pp. 695-674
- Carney, M.P.W.¹ Roth, M.² Garside, R.F.³

2
- 0242637890
- Freedom of Information Act 5. US Congress 552 (1994, Supp. II 1996) Available at http://www.usdoj.gov/04foia/. Accessed January 21, 1999.
- (1994) U.S. Congress 552 , Issue.SUPPL. II 1996

3
- 72949151592
- A rating scale for depression
- Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
- (1960) J Neurol Neurosurg Psychiatry , vol.23 , pp. 56-62
- Hamilton, M.¹

4
- 0034033736
- Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration Database
- Khan A, Warner HA, Brown WA (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration Database. Arch Gen Psychiatry 57:311-317.
- (2000) Arch Gen Psychiatry , vol.57 , pp. 311-317
- Khan, A.¹ Warner, H.A.² Brown, W.A.³

5
- 0242637899
- The continuing unethical use of placebo controls
- Rothman KJ, Michels KB (1995) The continuing unethical use of placebo controls. N Engl J Med 332:60-62.
- (1995) N Engl J Med , vol.332 , pp. 60-62
- Rothman, K.J.¹ Michels, K.B.²

6
- 0018082913
- Research diagnostic criteria: Rationale and reliability
- Spitzer R (1978) Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 35:773-782.
- (1978) Arch Gen Psychiatry , vol.35 , pp. 773-782
- Spitzer, R.¹

7
- 0034891506
- Suicide risk in placebo-controlled studies of major depression
- Storosum JG, van Zwieten BJ, van den Brink W, Gersons BPR, Broekmans AW (2001) Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 158:1271-1275.
- (2001) Am J Psychiatry , vol.158 , pp. 1271-1275
- Storosum, J.G.¹ Van Zwieten, B.J.² Van den Brink, W.³ Gersons, B.P.R.⁴ Broekmans, A.W.⁵

8
- 0037051872
- Placebo response in studies of major depression
- Walsh BT, Seidman SN, Sysko R, Gould M (2002) Placebo response in studies of major depression. JAMA 287:1840-1847.
- (2002) JAMA , vol.287 , pp. 1840-1847
- Walsh, B.T.¹ Seidman, S.N.² Sysko, R.³ Gould, M.⁴

9
- 0003802728
- Declaration of Helsinki
- World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Available at: http://www.wma.net/e/policy/17-c_e.html. Accessed November 27, 2000.
- Ethical Principles for Medical Research Involving Human Subjects

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.